UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Prevalence of Advanced Parkinson's Disease in Patients Treated in the Hospitals of the Spanish National Healthcare System: The PARADISE Study

Brain sciences, 2021-11, Vol.11 (12), p.1557

2021

Link zum Volltext

Verfügbarkeit prüfen

Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease

NPJ Parkinson's Disease, 2021-11, Vol.7 (1), p.108-108, Article 108

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term effectiveness of levodopa-carbidopa intestinal gel in 177 Spanish patients with advanced Parkinson's disease

Neurodegenerative disease management, 2016-08, Vol.6 (4), p.289-298

2016

Link zum Volltext

Verfügbarkeit prüfen

A Spanish Consensus on the Use of Safinamide for Parkinson's Disease in Clinical Practice

Brain sciences, 2020-03, Vol.10 (3), p.176

2020

Link zum Volltext

Verfügbarkeit prüfen

Validation study of the Parkinson's Fatigue Scale in advanced Parkinson's disease

Patient related outcome measures, 2019-04, Vol.10, p.141-152

2019

Link zum Volltext

Verfügbarkeit prüfen

Psychometric Properties of the Apathy Scale in Advanced Parkinson’s Disease

Parkinson's disease, 2019-01, Vol.2019, p.1965394-8

2019

Link zum Volltext

Verfügbarkeit prüfen

LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1

Molecular neurobiology, 2018-01, Vol.55 (1), p.506-516

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation

Journal of Parkinson's disease, 2019-01, Vol.9 (1), p.173

2019

Link zum Volltext

Verfügbarkeit prüfen

Erratum: Pagonabarraga, J.; et al. A Spanish Consensus on the Use of Safinamide for Parkinson's Disease in Clinical Practice. Brain Sci. 2020, 10 , 176

Brain sciences, 2020-05, Vol.10 (5), p.313

2020

Link zum Volltext

Verfügbarkeit prüfen

Deep brain stimulation in parkinsonian patients with dopa intolerance

Neurocirugia (Asturias, Spain), 2018-07, Vol.29 (4), p.213

2018

Link zum Volltext

Verfügbarkeit prüfen

Improvement of impulse control disorders associated with levodopa–carbidopa intestinal gel treatment in advanced Parkinson’s disease

Journal of neurology, 2018-06, Vol.265 (6), p.1279-1287

2018

Link zum Volltext

Verfügbarkeit prüfen

Tratamiento con Duodopa: inconvenientes

Revista de neurologiá, 2010-01, Vol.50 (S01), p.55

Arbelo González, José Matías

2010

Link zum Volltext

Verfügbarkeit prüfen

Complicaciones del tratamiento en la enfermedad de Parkinson. ¿Mejor cirugía que infusiones?

Revista de neurologiá, 2010-05, Vol.50 (S04), p.52

Arbelo González, José Matías

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical manifestations of intermediate allele carriers in Huntington disease

Neurology, 2016-08, Vol.87 (6), p.571

2016

Link zum Volltext

Verfügbarkeit prüfen

Cognitive decline in Huntington's disease expansion gene carriers

Cortex, 2017-10, Vol.95, p.51-62

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical and genetic characteristics of late-onset Huntington's disease

Parkinsonism & related disorders, 2019-04, Vol.61, p.101-105

2019

Link zum Volltext

Verfügbarkeit prüfen

Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study

Brain sciences, 2019-10, Vol.9 (10), p.272

2019

Link zum Volltext

Verfügbarkeit prüfen

Estimulación cerebral profunda en pacientes parkinsonianos con intolerancia a levodopa

Neurocirugía (Asturias, Spain), 2018-07, Vol.29 (4), p.213-215

2018

Link zum Volltext

Verfügbarkeit prüfen

COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

BMC neurology, 2016-02, Vol.16 (1), p.26-26, Article 26

2016

Link zum Volltext

Verfügbarkeit prüfen

Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study

Journal of Huntington's disease, 2018, Vol.7 (3), p.209

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Parkinson Disease, Time and Dosage: “Does Simple Dosage Facilitate Compliance and Therapeutic Goals?”

The Neurologist (Baltimore, Md.), 2011-11, Vol.17 Current Scientific Evidence and Future Possibilities in Parkinson Disease (6 Suppl 1), p.S43-S46

2011

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

BMC neurology, 2016-04, Vol.16 (44), p.44-44, Article 44

2016

Link zum Volltext

Verfügbarkeit prüfen

Mitos y evidencias en el empleo de la toxina botulínica: espasticidad del adulto y del niño con parálisis cerebral

Revista de neurologiá, 2017-05, Vol.64 (10), p.459

2017

Link zum Volltext

Verfügbarkeit prüfen

Validation study of the Parkinson's Fatigue Scale in advanced Parkinson's disease.(ORIGINAL RESEARCH)(Clinical report)

Patient related outcome measures, 2020-03, p.141

2020

Link zum Volltext

Verfügbarkeit prüfen

Advances in Drug Therapy : Alternative Treatments For The Control of Motor Fluctuations and Dyskinesias

Arbelo González, José Matías

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)
Buchkapitel
(1)

Sprache

Englisch
(21)
Spanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence of Advanced Parkinson's Disease in Patients Treated in the Hospitals of the Spanish National Healthcare System: The PARADISE Study

Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease

Long-term effectiveness of levodopa-carbidopa intestinal gel in 177 Spanish patients with advanced Parkinson's disease

A Spanish Consensus on the Use of Safinamide for Parkinson's Disease in Clinical Practice

Validation study of the Parkinson's Fatigue Scale in advanced Parkinson's disease

Psychometric Properties of the Apathy Scale in Advanced Parkinson’s Disease

LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1

Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation

Erratum: Pagonabarraga, J.; et al. A Spanish Consensus on the Use of Safinamide for Parkinson's Disease in Clinical Practice. Brain Sci. 2020, 10 , 176

Deep brain stimulation in parkinsonian patients with dopa intolerance

Improvement of impulse control disorders associated with levodopa–carbidopa intestinal gel treatment in advanced Parkinson’s disease

Tratamiento con Duodopa: inconvenientes

Complicaciones del tratamiento en la enfermedad de Parkinson. ¿Mejor cirugía que infusiones?

Clinical manifestations of intermediate allele carriers in Huntington disease

Cognitive decline in Huntington's disease expansion gene carriers

Clinical and genetic characteristics of late-onset Huntington's disease

Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study

Estimulación cerebral profunda en pacientes parkinsonianos con intolerancia a levodopa

COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study

Treatment of Parkinson Disease, Time and Dosage: “Does Simple Dosage Facilitate Compliance and Therapeutic Goals?”

Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

Mitos y evidencias en el empleo de la toxina botulínica: espasticidad del adulto y del niño con parálisis cerebral

Validation study of the Parkinson's Fatigue Scale in advanced Parkinson's disease.(ORIGINAL RESEARCH)(Clinical report)

Advances in Drug Therapy : Alternative Treatments For The Control of Motor Fluctuations and Dyskinesias

Suchergebnisse filtern